Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 3/20 | 0.37 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10265436 | 0.85 | PTGS2 (0.45) | PTGS2ALDH1A1KDM4EHTTPOLB | |
| SCHEMBL10265709 | 0.80 | PTGS2 (0.43) | PTGS2ALDH1A1KDM4EHTTPOLB | |
| SCHEMBL318187 | 0.80 | PTGS2 (0.41) | PTGS2ALDH1A1KDM4EHTTPOLB | |
| SCHEMBL10265406 | 0.80 | RAF1 (0.47) | PTGS2 | |
| SCHEMBL10265728 | 0.80 | PTGS2 (0.45) | PTGS2ALDH1A1KDM4EHTTPOLB | |
| SCHEMBL10265386 | 0.78 | PTGS2 (0.44) | PTGS2ALDH1A1KDM4EHTTPOLB | |
| SCHEMBL325276 | 0.78 | CYP2E1 (0.47) | PTGS2ALDH1A1KDM4EHTTPOLB | |
| SCHEMBL320070 | 0.77 | MAPT (0.54) | PTGS2ALDH1A1KDM4EHTTPOLB | |
| SCHEMBL318967 | 0.77 | PTGS2 (0.41) | PTGS2ALDH1A1KDM4EHTTPOLB | |
| SCHEMBL319003 | 0.77 | PTGS2 (0.41) | PTGS2ALDH1A1KDM4EHTTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2585447-A2 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | Vertex Pharmaceuticals Incorporated (US) | 2013-05-01 | — | — | EP | disclosed |
| WO-2012006055-A2 | COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-01-12 | — | — | WO | disclosed |